Adenovirus transduction is required for the correction of diabetes using Pdx-1 or Neurogenin-3 in the liver (Q44934854)

7 December 2017

title

Adenovirus transduction is required for the correction of diabetes using Pdx-1 or Neurogenin-3 in the liver (English)

1 reference

7 December 2017

1 reference

Alfred Y Wang

1

1 reference

7 December 2017

Anja Ehrhardt

series ordinal

2

1 reference

7 December 2017

Hui Xu

series ordinal

3

1 reference

7 December 2017

Mark A Kay

series ordinal

4

1 reference

7 December 2017

publication date

1 February 2007

1 reference

7 December 2017

1 reference

7 December 2017

volume

15

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

255-263

1 reference

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Gene therapy progress and prospects: gene therapy for diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Approaches for the cure of type 1 diabetes by cellular and gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Pancreatic islet transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Stem cells and regenerative medicine for diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Genes, Signals, and Lineages in Pancreas Development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Insulin-promoter-factor 1 is required for pancreas development in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

beta-cell neogenesis induced by adenovirus-mediated gene delivery of transcription factor pdx-1 into mouse pancreas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Pancreatic-hepatic switches in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Functional, persistent, and extended liver to pancreas transdifferentiation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

A crucial role of MafA as a novel therapeutic target for diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

RAG-1-deficient mice have no mature B and T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Extrapancreatic insulin-producing cells in multiple organs in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Immune responses to gene therapy vectors: influence on vector function and effector mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Molecular basis of the inflammatory response to adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Expansion of donor hepatocytes after recombinant adenovirus-induced liver regeneration in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Improved system for helper-dependent adenoviral vector production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300032

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300032

1 reference

7 December 2017

1 reference